Epithelial:
The epithelial segment of the ovarian cancer treatment drugs market is expected to witness significant growth due to the high prevalence of epithelial ovarian cancer.
Targeted therapy and chemotherapy are the most commonly used treatment types for epithelial ovarian cancer.
Hospitals and cancer treatment centers are the primary end-users for drugs targeting epithelial ovarian cancer.
Stromal:
The stromal segment of the ovarian cancer treatment drugs market size is anticipated to grow steadily, driven by advancements in targeted therapy and immunotherapy.
Stromal ovarian cancer is typically treated through oral administration of drugs, making it convenient for patients.
Academic research institutions and specialty clinics are key end-users for stromal ovarian cancer drugs.
Germ Cell:
The germ cell segment of the ovarian cancer treatment drugs market is expected to experience rapid growth due to the rising incidence of germ cell ovarian cancer.
Chemotherapy is the primary treatment type for germ cell ovarian cancer, with intravenous administration being the preferred route.
Cancer hospitals and outpatient clinics are the main end-users for drugs targeting germ cell ovarian cancer.